These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11367322)

  • 1. Expanded access program for ABT-378 under way.
    Slovick J
    Posit Living; 1999 Nov; 8(10):10. PubMed ID: 11367322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-378 early access program begins.
    AIDS Treat News; 1999 Oct; (No 328):1-2. PubMed ID: 11366816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upcoming compassionate use programs for two new antiretrovirals will begin this fall.
    Schouten J
    STEP Perspect; 1999; 99(3):16. PubMed ID: 11366864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded access.
    Proj Inf Perspect; 1999 Sep; (28):8. PubMed ID: 11367366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAAC: new drugs in late breaker session.
    James JS
    AIDS Treat News; 1999 Oct; (No 328):3-5. PubMed ID: 11366817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABT-387/r early access program expanded further.
    Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ritonavir expanded access.
    GMHC Treat Issues; 1995 Dec; 9(12):8. PubMed ID: 11363000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug works in treatment-naive, experienced patients.
    AIDS Alert; 1999 Dec; 14(12):136. PubMed ID: 11366988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitor studies enrolling.
    Treat Rev; 1995; (no 17):3. PubMed ID: 11362296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early access program for ABT-378/r.
    Highleyman L
    BETA; 1999; 12(4):3-4. PubMed ID: 11367247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abbott agrees to implement a compassionate use program for Ritonavir.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):38. PubMed ID: 11362798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded access programs expanding.
    Proj Inf Perspect; 1997 Nov; (23):20-1. PubMed ID: 11365376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What they say about: protease inhibitors.
    Posit Aware; 2000; 11(1):48-54. PubMed ID: 11366351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbott protease inhibitor lottery in January, CD4 under 50--registration now.
    AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaletra approved in Canada.
    TreatmentUpdate; 2001; 12(11):1-2. PubMed ID: 11570069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
    Murphy RL
    Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New treatments for HIV].
    Garcia E
    Sidahora; 1996; ():48-50. PubMed ID: 11363630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ritonavir, Abbott protease inhibitor, approved.
    AIDS Treat News; 1996 Mar; (no 243):2-3. PubMed ID: 11363300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral approved for use in infants.
    Am Fam Physician; 2001 Jun; 63(12):2469. PubMed ID: 11430459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.